Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

111 - 120 of 5575 results found

Arterial and venous thrombotic stroke after ChAdOx1 nCoV-19 vaccine

Date
Monday, April 08, 2024 - 4:00 AM
Description
Vaccine-induced thrombosis with thrombocytopenia (VITT) is a recently-described condition associated with arterial and venous thrombosis following vaccination with the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. This report describes two cases of stroke

Assembly of SARS-CoV-2 nucleocapsid protein with nucleic acid

Date
Monday, April 08, 2024 - 4:00 AM
Description
The viral genome of SARS-CoV-2 is packaged by the nucleocapsid (N-)protein into ribonucleoprotein particles (RNPs), 38 ± 10 of which are contained in each virion. Their architecture has remained unclear due to the pleomorphism of RNPs, the high

Assessing quality of critical care during an ongoing health emergency in a resource-limited setting: A novel approach to evaluate the quality of care in Lebanese public ICUs during the COVID-19 pandemic

Date
Saturday, April 06, 2024 - 4:00 AM
Description
CONCLUSION: We present a feasible way to assess quality of care in ICUs and how it can be used in assessing a quality improvement project during ongoing crises in resource-limited settings. By implementing a quality of care intervention in Lebanon's

A comparative analysis of TCR immune repertoire in COVID-19 patients

Date
Saturday, April 06, 2024 - 4:00 AM
Description
The coronavirus disease 2019 (COVID-19) has merged as a global health threat since its outbreak in December 2019. Despite widespread recognition, there has been a paucity of studies focusing on the T cell receptor (TCR) bias in adaptive immunity

Alcohol-Related liver disease: A global perspective

Date
Saturday, April 06, 2024 - 4:00 AM
Description
Alcohol-associated liver disease (ALD) represents one of the deadliest yet preventable consequences of excessive alcohol use. It represents 5.1% of the global burden of disease, mainly involving the productive-age population (15-44 years) and leading